Research ties insulin to higher mortality risk in diabetes

01/14/2013 | FoodConsumer.org

Type 2 diabetes patients who were on insulin treatment had an 89% higher risk of all-cause mortality and 116% higher risk of cancer-related death than nonusers, a study revealed. However, researchers noted diabetes patients on insulin did not have a higher overall risk of cancer. The findings appear in PLoS One.

View Full Article in:

FoodConsumer.org

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC